These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25190699)

  • 1. Gene panel testing for inherited cancer risk.
    Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast cancer syndromes and genetic testing.
    Rich TA; Woodson AH; Litton J; Arun B
    J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for cancer susceptibility genes in children.
    Laxova R
    Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    King E; Mahon SM
    Clin J Oncol Nurs; 2017 Oct; 21(5):589-598. PubMed ID: 28945723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
    Marcus RK; Geurts JL; Grzybowski JA; Turaga KK; Clark Gamblin T; Strong KA; Johnston FM
    Fam Cancer; 2015 Dec; 14(4):641-9. PubMed ID: 26108897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
    Lewis KM
    Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited kidney cancer syndromes.
    Ball MW; Shuch BM
    Curr Opin Urol; 2019 Jul; 29(4):334-343. PubMed ID: 31083011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
    Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
    J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
    Meiser B; Storey B; Quinn V; Rahman B; Andrews L
    J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients in Whom to Consider Genetic Evaluation and Testing for Hereditary Colorectal Cancer Syndromes.
    Kupfer SS; Burke CA
    Am J Gastroenterol; 2020 Jan; 115(1):1-4. PubMed ID: 31634263
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of the oncogenetic molecular counselling in adults whith familial cancer].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Rev Med Inst Mex Seguro Soc; 2016; 54(3):364-74. PubMed ID: 27100983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk assessment, counseling and testing.
    Rich TA; Salazar M
    Surg Oncol Clin N Am; 2009 Jan; 18(1):19-38, vii. PubMed ID: 19056040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hereditary cancer gene panels on clinical care and lessons learned.
    Okur V; Chung WK
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
    LaDuca H; Stuenkel AJ; Dolinsky JS; Keiles S; Tandy S; Pesaran T; Chen E; Gau CL; Palmaer E; Shoaepour K; Shah D; Speare V; Gandomi S; Chao E
    Genet Med; 2014 Nov; 16(11):830-7. PubMed ID: 24763289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigene Testing for Hereditary Cancer: When, Why, and How.
    Offit K
    J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.